Oberon Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 4.48 M
- Company Age 14 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.00 M
- Satisfied Charges ₹ 3.00 M
- Revenue Growth -26.37%
- Profit Growth -5630.92%
- Ebitda 13.51%
- Net Worth -59.57%
- Total Assets -14.25%
About Oberon Pharmaceuticals
Oberon Pharmaceuticals Private Limited (OPPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 April 2010 and has a history of 14 years and ten months. Its registered office is in Thrissur, Kerala, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.48 M.
The company currently has active open charges totaling ₹4.00 M. The company has closed loans amounting to ₹3.00 M, as per Ministry of Corporate Affairs (MCA) records.
Visembharan Jithin and Joseph serve as directors at the Company.
Company Details
- Location
Thrissur, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24233KL2010PTC025908
- Company No.
025908
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Apr 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Pharma
Who are the key members and board of directors at Oberon Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Visembharan Jithin  | Managing Director | 03-Jul-2023 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Alby Joseph | Director | 03-Jul-2023 | Current |
Financial Performance of Oberon Pharmaceuticals.
Oberon Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 26.37% decrease. The company also saw a substantial fall in profitability, with a 5630.92% decrease in profit. The company's net worth observed a substantial decline by a decrease of 59.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oberon Pharmaceuticals?
In 2021, Oberon Pharmaceuticals had a promoter holding of 7.04% and a public holding of 92.96%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Zenith Affiliates Llp
Visembharan Jithin is a mutual person
- P&J Health Seekers Private Limited
Visembharan Jithin and . Joseph are mutual person
- P&J Productions Private Limited
Visembharan Jithin and . Joseph are mutual person
Charges (Loans)
Open Charges
₹4.00 M
Satisfied Charges
₹3.00 M
Charges Breakdown by Lending Institutions
- Others : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Oct 2016 | Others | ₹4.00 M | Open |
| 08 Dec 2011 | The Catholic Syrian Bank Limited | ₹3.00 M | Satisfied |
How Many Employees Work at Oberon Pharmaceuticals?
Unlock and access historical data on people associated with Oberon Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oberon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oberon Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
